Firefly Neuroscience (AIFF) Price to Sales (2010 - 2026)

Firefly Neuroscience has reported Price to Sales for 16 years, with the latest figure at 48.44 in Q2 2026.

• On a quarterly basis, Price to Sales fell 61.51% year-over-year to 48.44 in Q2 2026; TTM through Jun 2026 was 13.84, a 84.59% decrease from a year earlier, with the FY2025 full-year figure at 10.76, down 93.3% from the prior year.
• Price to Sales was 48.44 for Q2 2026 at Firefly Neuroscience, down from 66.82 in the prior quarter.
• The five-year high for Price to Sales was 1466.31 in Q2 2024, with the low at 2.59 in Q1 2023.
• Average Price to Sales over 5 years is 259.57, with a median of 66.82 recorded in 2026.
• The sharpest annual moves came in 2024 and 2026: Price to Sales soared 49623.38% in 2024, then plunged 93.74% in 2026.
• Over 5 years, Price to Sales stood at 4.67 in 2022, then surged by 3735.71% to 179.07 in 2023, then jumped by 161.64% to 468.5 in 2024, then tumbled by 93.63% to 29.83 in 2025, then soared by 62.42% to 48.44 in 2026.
• The last three Price to Sales figures came in at 48.44 (Q2 2026), 66.82 (Q1 2026), and 29.83 (Q4 2025), per Business Quant data.